文献速递乳腺MR

超快速与标准二维动态对比增强乳腺MRI的个体内比较

Intraindividual Comparison of Ultrafast versus Standard Two-dimensional Dynamic Contrast-enhanced Breast MRI.
PubMed 文献 · Radiology · 2025-01-01

该回顾性研究对31例女性在2天内先后行标准DCE MRI与超快速MRI,比较59个强化病灶的显示清晰度和分类能力。超快速MRI背景实质强化评分平均低0.8分,但病灶清晰度与图像质量均更低,且动力学参数未改善病灶分类。

要点

  • 超快速MRI背景实质强化评分较标准DCE MRI平均低0.8分,但病灶清晰度与图像质量也更低。
  • 超快速MRI对病灶形态学(形状、边缘、内部结构)的评估能力均低于标准DCE MRI。
  • 超快速MRI动力学参数未改善强化病灶的良恶性分类,仅恶性病灶强化时间更短。

核心结论

  • 在这个预期超快速MRI优于DCE MRI的富集队列中,超快速MRI实际上导致病灶清晰度降低,且未改善病灶分类。

研究设计与样本

  • 回顾性分析31例女性(中位年龄48岁,IQR 39-51岁),2021年9月至2023年1月行1.5 T DCE MRI及2天内超快速MRI,参考标准为对难判读强化病灶和/或BPE的进一步诊断评估。

关键影像表现/征象

  • 超快速MRI背景实质强化评分平均较DCE MRI低0.8分(均值2.5±1.2 vs 3.3±1.2,P < .001)。
  • 超快速MRI病灶清晰度评分低于DCE MRI(均值3.5±1.3 vs 4.1±1.0,P = .001)。
  • 超快速MRI图像质量评分低于DCE MRI(均值2.3±0.9 vs 4.1±0.8,P < .001)。
  • 超快速MRI对病灶形态学(形状、边缘、内部结构)的可评估性均低于DCE MRI(均P < .05)。

诊断标准与关键数值

  • 超快速MRI:恶性病灶强化时间短于良性病灶(P = .01),但最大斜率无差异。
  • DCE MRI:恶性与良性病灶的流入速率和时间过程模式均有差异(均P = .01)。

临床应用与阅片要点

  • 在预期超快速MRI有诊断优势的富集队列中,超快速MRI实际导致病灶清晰度降低,且未改善病灶分类。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Ultrafast breast MRI promises to improve conspicuity of cancers by avoiding masking due to background parenchymal enhancement (BPE) and to improve classification of enhancing lesions. However, published studies systematically penalized standard dynamic contrast-enhanced (DCE) MRI because they integrated ultrafast MRI into existing DCE protocols, such that postcontrast acquisitions of DCE MRI began only after completion of ultrafast MRI. Purpose To perform an intraindividual comparison of conspicuity and classification of enhancing breast lesions with ultrafast MRI versus standard DCE MRI, where both methods included the early postcontrast phase. Materials and Methods This was a retrospective analysis of 31 women (median age, 48 years [IQR, 39-51 years]) from September 2021 to January 2023. Women underwent DCE MRI at 1.5 T and, within 2 days, a second contrast-enhanced examination using ultrafast MRI, for further diagnostic assessment of difficult-to-interpret enhancing lesions and/or BPE. For DCE MRI, a two-dimensional gradient-echo series (0.61 × 0.61 × 3.0-mm spatial resolution, 60 seconds per dynamic frame) was obtained once before and four times after injection of 0.1 mmol/kg gadobutrol. For ultrafast MRI, a compressed-sense accelerated three-dimensional gradient-echo series (0.92 × 0.97 × 2.5-mm spatial resolution, 4 seconds per keyhole dynamic frame) was obtained over 90 seconds before, during, and after injection of 0.1 mmol/kg gadobutrol. Two breast radiologists independently rated BPE, image quality, and conspicuity and morphology of enhancing lesions, and enhancement kinetics were analyzed (ultrafast MRI: maximum slope and time to enhancement; DCE MRI: wash-in rate and time course pattern). Results A total 59 enhancing lesions were reported in the 62 breasts of the 31 patients. BPE ratings were on average 0.8 points lower at ultrafast versus DCE MRI (mean, 2.5 ± 1.2 [SD] vs 3.3 ± 1.2; P < .001). Despite this mild reduction in BPE, lesion conspicuity was rated lower at ultrafast than at DCE MRI (mean, 3.5 ± 1.3 vs 4.1 ± 1.0; P = .001), as was image quality (mean, 2.3 ± 0.9 vs 4.1 ± 0.8; P < .001). Lesion morphology (shape, margin, internal architecture) was less assessable at ultrafast MRI (all P < .05). Kinetic parameters derived from ultrafast MRI did not improve classification of enhancing lesions compared with those derived from DCE MRI: At ultrafast MRI, time to enhancement was shorter for malignant versus benign lesions (P = .01), but maximum slope did not differ, whereas at DCE MRI, both wash-in rate and time course pattern differed between malignant and benign lesions (both P = .01). Conclusion In this enriched cohort in which ultrafast MRI was expected to provide diagnostic advantages over DCE MRI, ultrafast MRI in fact led to reduced lesion conspicuity and did not improve lesion classification. © RSNA, 2025 Supplemental material is available for this article. See also the editorial by Cotes and Jacobs in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Bode M, Morscheid S, Iordanishvili E, et al. Intraindividual Comparison of Ultrafast versus Standard Two-dimensional Dynamic Contrast-enhanced Breast MRI. Radiology. 2025. PMID: 40326874. doi:10.1148/radiol.241371

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。